These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19538066)

  • 1. Noninferiority of linezolid for skin and bloodstream infections.
    Drekonja DM
    Clin Infect Dis; 2009 Jul; 49(2):312; author reply 314-5. PubMed ID: 19538066
    [No Abstract]   [Full Text] [Related]  

  • 2. Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study".
    Lustberg ME; Schlesinger LS; Mangino JE
    Clin Infect Dis; 2009 Jul; 49(2):313; author reply 314-5. PubMed ID: 19538067
    [No Abstract]   [Full Text] [Related]  

  • 3. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):395-406. PubMed ID: 15280870
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid.
    Kyle SD; Porter WM
    Br J Dermatol; 2004 Nov; 151(5):1101. PubMed ID: 15541095
    [No Abstract]   [Full Text] [Related]  

  • 6. Linezolid therapy of bloodborne teicoplanin-resistant Staphylococcus haemolyticus.
    Mohammedi I; Malhière S; Robert D; Charveriat MA; Etienne J
    Infection; 2006 Oct; 34(5):292-3. PubMed ID: 17033757
    [No Abstract]   [Full Text] [Related]  

  • 7. Linezolid resistance in three isolates of coagulase-negative staphylococci.
    Cieloszyk K; Amodio-Groton M; Saeed M; Coyle CM
    Ann Pharmacother; 2007 Mar; 41(3):526-7. PubMed ID: 17341527
    [No Abstract]   [Full Text] [Related]  

  • 8. Cochrane in context: Linezolid versus vancomycin for skin and soft tissue infections.
    Steiner M
    Evid Based Child Health; 2014 Mar; 9(1):167-8. PubMed ID: 25404580
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical failures of linezolid and implications for the clinical microbiology laboratory.
    Potoski BA; Mangino JE; Goff DA
    Emerg Infect Dis; 2002 Dec; 8(12):1519-20. PubMed ID: 12498678
    [No Abstract]   [Full Text] [Related]  

  • 10. Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia.
    Castagnola E; Moroni C; Gandullia P; Oddone M; Peri C; Casciaro R; De Alessandri A
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1120-1. PubMed ID: 16495284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Bodmann KF
    Pharm Unserer Zeit; 2004; 33(1):38-41. PubMed ID: 14968711
    [No Abstract]   [Full Text] [Related]  

  • 12. Linezolid, quinupristin/dalfopristin, and daptomycin in dermatology.
    Wesson KM; Lerner DS; Silverberg NB; Weinberg JM
    Clin Dermatol; 2003; 21(1):64-70. PubMed ID: 12609590
    [No Abstract]   [Full Text] [Related]  

  • 13. Resumption of linezolid therapy after myelotoxicity.
    McNamee WB
    Clin Infect Dis; 2003 Sep; 37(5):741-2. PubMed ID: 12942417
    [No Abstract]   [Full Text] [Related]  

  • 14. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
    Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
    Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid in postneurosurgical infections.
    Maure B; Martínez-Vázquez C; Argibay A; Pérez-Veloso M; Rodríguez Fernández MJ; Sopeña B
    Infection; 2008 Feb; 36(1):82-3. PubMed ID: 18165859
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
    Brickner SJ; Barbachyn MR; Hutchinson DK; Manninen PR
    J Med Chem; 2008 Apr; 51(7):1981-90. PubMed ID: 18338841
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature.
    Jasovich A; Ganaha MC; Ebi C; García RD; Blanco MA; Lopardo H
    Rev Argent Microbiol; 2008; 40(4):204-7. PubMed ID: 19213241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
    Mave V; Garcia-Diaz J; Islam T; Hasbun R
    J Antimicrob Chemother; 2009 Jul; 64(1):175-80. PubMed ID: 19423543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid.
    Morosi S; Francisci D; Baldelli F
    J Infect; 2006 Mar; 52(3):e73-5. PubMed ID: 16126275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teeth and tongue discoloration during linezolid therapy.
    Ma JS
    Pediatr Infect Dis J; 2009 Apr; 28(4):345-6. PubMed ID: 19238109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.